Skip to main content
SpringerLink
Log in

Enhanced oxidative burst without interleukin 1 production by normal human polymorphonuclear leukocytes primed with muramyl dipeptides

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Purified polymorphonuclear (PMN) cells were obtained from human blood leukocytes by centrifugation on colloidal silica gradients. PMNs could be primed for PMA-triggered oxidative burst by muramyl peptide molecules (MDP) and two of its adjuvant active nonpyrogenic derivatives. The priming effect of MDP could be demonstrated after a 1-h incubation period, whereas monocytes needed an 18-h incubation to produce an enhanced response in the NBT reduction test. Only the monocyte-enriched population was able to produce IL-1 activity after muramyl peptide stimulation. Under such conditions, PMNs neither produced nor secreted IL-1-like activity, and no IL-1 inhibitor was present in the supernatant fluids. In conclusion, muramyl peptides were able to prime PMNs for oxidative burst but not to stimulate IL-1-like factor production.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Osada, Y., T. Otani, M. Sato, T. Une, K. Matsumoto, andH. Ogawa. 1982. Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog.Infect. Immun. 38:848–854.

    Google Scholar 

  2. Chedid, L., M. Parant, F. Parant, P. Lefrancier, J. Choay andE. Lederer. 1977. Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetyl muramyl-l-alanyl-d-isoglutamine) and several analogs.Proc. Natl. Acad. Sci. U.S.A. 74:2089–2093.

    Google Scholar 

  3. Morikawa, K., R. Takeda, M. Yamazaki, andD. Mizuno. 1985. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linearβ-1,3-d-glucan and other immunomodulators in murine cells.Cancer Res. 45:1469–1501.

    Google Scholar 

  4. Kaku, M., K. Yagawa, S. Nagao, andA. Tanaka. 1983. Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide.Infect. Immun. 39: 559–564.

    Google Scholar 

  5. Giroud, J. P., M. Roch-Arveiller, O. Muntaner, andD. Bradshaw. 1980. Action comparée du lévamisole, du muramyl dipeptide et de la tuftsine sur le chimiotactisme des polynucléaires de rat.Nouv. Rev. Fr. Hematol. 22:69–76.

    Google Scholar 

  6. Ogawa, T., H. Takada, S. Kotani, S. Kusumoto, T. Shiba, S. Kawata, K. Yokogawa, andA. Inoue. 1981. Basophile leukocyte stimulation by bacterial cell walls and related compounds.In Immunomodulation by Microbial Products and Related Synthetic Compounds. Y. Yamamura, S. Kotani, I. Azuma, A. Koda, and T. Shiba, editors. Excerpta Medica, Amsterdam. 221–224.

    Google Scholar 

  7. Ishihara, Y., H. Takada, S. Kotani, S. Kusumoto, T. Shiba, S. Kawata, andK. Kokogawa. 1981. Stimulation of polymorphonuclear leukocytes by bacterial cell wall components and related synthetic compounds.In Immunomodulation by Microbial Products and Related Synthetic Compounds. Y. Yamamura, S. Kotani, I. Azuma, A. Koda, and T. Shiba, editors. Excerpta Medica, Amsterdam. 217–220.

    Google Scholar 

  8. Beeson, P. 1948. Temperature elevating effect of a substance obtained from polymorphonuclear leukocytes.J. Clin. Invest. 27:524 (abstract).

    Google Scholar 

  9. Dinarello, C., N. Goldin, andS. Wolff. 1974. Demonstration and characterization of two distinct human leukocytic pyrogens.J. Exp. Med. 139:1369–1381.

    Google Scholar 

  10. Yoshinaga, M., S., Nakamura, andH. Hayashi. 1975. Interaction between lymphocytes and inflammatory exudate cells. I. Enhancement of thymocyte response to PHA by product(s) of polymorphonuclear leukocytes and macrophages.J. Immunol. 115:533–538.

    Google Scholar 

  11. Yoshinaga, M., F. Goto, K. Goto, S. Ohkawara, S. Nakamura, M. Kitamura, andH. Takahashi. 1985. Biosynthesis and purification of IL-1 like factor from polymorphonuclear leukocytes of rabbits with tumor-induced granulocytosis.In The Physiologic, Metabolic, and Immunologic Actions of Interleukin-1. M. J. Klüger, J. J. Oppenheim, and M. Powanda, editors. Alan R. Liss, New York. 385–398.

    Google Scholar 

  12. Goto, F., S. Nakamura, K. Goto, andM. Yoshinaga, 1984. Production of a lymphocyte proliferation potentiating factor by purified polymorphonuclear leucocytes from mice and rabbits.Immunology 53:638–691.

    Google Scholar 

  13. Goto, K., S. Nakamura, F. Goto, andM. Yoshinaga. 1984. Generation of an interleukin 1-like lymphocyte-stimulating factor at inflammatory sites: Correlation with the infiltration of polymorphonuclear leucocytes.Br. J. Exp. Pathol. 65:521–532.

    Google Scholar 

  14. Windle, B. E., P. Murphy, andS. Cooperman. 1983. Rabbit polymorphonuclear leukocytes do not secrete endogenous pyrogens or interleukin 1 when stimulated by endotoxin, polyinosine: polycytosine, or muramyl dipeptide.Infect. Immun. 39:1142–1146.

    Google Scholar 

  15. Damais, C., G. Riveau, M. Parant, J. Gerota, andL. Chedid. 1982. Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative.Int. J. Immunopharmacol. 4:451–462.

    Google Scholar 

  16. Lefrancier, P., M. Derrien, X. Jamet, J. Choay, E. Lederer, F. Audibert, M. Parant, F. Parant, andL. Chedid. 1982. Apyrogenic adjuvant-activeN-acetyl-muramyl dipeptides.J. Med. Chem. 25:87–90.

    Google Scholar 

  17. Feige, U., B. Overwen, andC. Sorg. 1982. Purification of human blood monocytes by hypotonic density gradient centrifugation in Percoll.J. Immunol. Methods 54:309–315.

    Google Scholar 

  18. Bertoglio, J., N. Boisson, M. Bonnet, L. Chatenoud, S. Chouaib, G. Degiovanni, D. Fradelizi, A. Godard, P. Goube de la Foret, A. Harel-Bellan, R. Jacubovich, M. Lacaze, T. Lahaye, M. Mousalayi, M. Pla, A. Rey, E. Rotschild, C. Schmitt, B. Serrou, J. Soulillou, F. Tribel, andA. Ythier. 1982. First French workshop on standardization of human IL-2: Joint report.Lymphokine Res. 1:121–127.

    Google Scholar 

  19. Pick, E., J. Charon, andD. Mizel. 1981. A rapid densitometric micro-assay for nitroblue tetrazolium reduction and application of the microassay to macrophages.J. Res. 30:581–593.

    Google Scholar 

  20. Pabst, M., H. Hedesgaard, andR. Johnston. 1982. Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response.J. Immunol. 128:123–128.

    Google Scholar 

  21. Chedid, L., M. Parant, F. Audibert, G. Riveau, F. Parant, E. Lederer, J. Choay, andP. Lefrancier. 1982. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.Infect. Immun. 35:417–424.

    Google Scholar 

  22. Tiku, K., J. Skosey, andM. Tiku. 1985. Neutrophil production of an interleukin-1 inhibitor.J. Leuk. Biol. 37:747 (abstract).

    Google Scholar 

  23. Tiku, K., M. Tiku, andJ. Skosey. 1985. Description of a neutrokine: A neutrophil derived thymocyte activating factor with interleukin-1-like activity.J. Leuk. Biol. 37:748 (abstract).

    Google Scholar 

  24. Petrone, W., D. English, K. Wong, andJ. McCord. 1980. Free radicals and inflammation: Superoxide-dependent activation of a neutrophil chemotactic factor in plasma.Proc. Natl. Acad. Sci. U.S.A. 77:1159–1163.

    Google Scholar 

  25. Atkins, E., P. Bodel, andL. Francis. 1967. Release of an endogenous pyrogen in vitro from rabbit mononuclear cells.J. Exp. Med. 126:357–384.

    Google Scholar 

  26. Hahn, H., D. Char, W. Postel, andW. B. Wood. 1967, The production of endogenous pyrogen by peritoneal macrophages.J. Exp. Med. 126:385–394.

    Google Scholar 

  27. Kampschmidt, R. 1978. Leukocytic endogenous mediator.J. Reticuloendothel. Soc. 23:287–297.

    Google Scholar 

  28. Hanson, D., P. Murphy, andB. Windle. 1980. Failure of rabbit neutrophils to secrete endogenous pyrogen when stimulated with staphylococci.J. Exp. Med. 151:1360–1371.

    Google Scholar 

  29. Kampschmidt, R. 1981. Leukocytic endogenous mediator/endogenous pyrogen.In Infection. The Physiologic and Metabolic Responses of the Host. M. C. Powanda and P. G. Canonico, Editors. Elsevier/North Holland Press, Amsterdam. 56–74.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Immunothérapie expérimenale Institut Pasteur, CNRS UA579, Paris, France

    C. Jupin, M. Parant, L. Chedid & C. Damais

Authors
  1. C. Jupin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Parant
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Chedid
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Damais
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported in part by CNRS ATP-955335.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jupin, C., Parant, M., Chedid, L. et al. Enhanced oxidative burst without interleukin 1 production by normal human polymorphonuclear leukocytes primed with muramyl dipeptides. Inflammation 11, 153–161 (1987). https://doi.org/10.1007/BF00916017

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00916017

Keywords

Search

Navigation